Effect of Chlorogenic Acids on the Human Vasculature - Trial NCT03520452
Access comprehensive clinical trial information for NCT03520452 through Pure Global AI's free database. This phase not specified trial is sponsored by Société des Produits Nestlé (SPN) and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 22 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Société des Produits Nestlé (SPN)
Timeline & Enrollment
N/A
Mar 14, 2018
Dec 20, 2018
Primary Outcome
Efficacy by oral administration of chlorogenic acid in improving endothelial function
Summary
This study evaluates effects of different doses of chlorogenic acids on vascular health.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03520452
Non-Device Trial